|
gptkbp:instance_of
|
gptkb:Antihero
|
|
gptkbp:approves
|
1946
|
|
gptkbp:atccode
|
R06 AA02
|
|
gptkbp:available_in
|
gptkb:various_countries
|
|
gptkbp:available_on
|
gptkb:pharmaceuticals
|
|
gptkbp:brand
|
gptkb:Johnson_&_Johnson
gptkb:Benadryl_Allergy
gptkb:Benadryl_Children's
gptkb:Benadryl_Extra_Strength
|
|
gptkbp:casnumber
|
58-73-1
|
|
gptkbp:category
|
B
|
|
gptkbp:chemical_formula
|
C17 H22 N2 O
|
|
gptkbp:composed_by
|
synthetic compound
|
|
gptkbp:contraindication
|
gptkb:asthma
gptkb:Ophthalmology
prostate enlargement
|
|
gptkbp:discovered_by
|
gptkb:George_Rieveschl
|
|
gptkbp:dosage_form
|
oral
topical
|
|
gptkbp:form
|
gptkb:tablet
gptkb:capsule
gptkb:liquid
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Benadryl
|
|
gptkbp:ingredients
|
gptkb:diphenhydramine
|
|
gptkbp:interacts_with
|
gptkb:beer
MAO inhibitors
other antihistamines
|
|
gptkbp:legal_status
|
OTC
|
|
gptkbp:lifespan
|
4 to 8 hours
|
|
gptkbp:marketed_as
|
gptkb:Pfizer
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
gptkb:bottle
blister pack
|
|
gptkbp:related_products
|
gptkb:loratadine
gptkb:chlorpheniramine
gptkb:doxylamine
gptkb:hydroxyzine
gptkb:promethazine
cetirizine
fexofenadine
|
|
gptkbp:route_of_administration
|
oral
intravenous
topical
|
|
gptkbp:safety
|
not recommended for children under 2 years
may cause sedation
should not be used with other sedatives
|
|
gptkbp:side_effect
|
dizziness
drowsiness
constipation
dry mouth
blurred vision
|
|
gptkbp:used_for
|
insomnia
motion sickness
allergy relief
|
|
gptkbp:bfsParent
|
gptkb:Pfizer_Consumer_Healthcare
gptkb:JNJ
gptkb:Super_Bowl_XXXII
gptkb:Vicks
|
|
gptkbp:bfsLayer
|
5
|